13F
← All fund report cards

Avidian Wealth Enterprises, LLC

13F equity value
$3.2B
Positions
662
Top 10 concentration
39.1%
Quarters / total new picks
32 / 681
13F equity value over time
$0M$2B$3B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +4.0% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = -0.39, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.6%
t-stat
-0.39
Quarterly win rate
50%
Annualized excess
+4.3%
$1 → follow vs universe
$2.84 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.99920180630: follow 0.93420180930: follow 0.99520181231: follow 0.97020190331: follow 0.99920190630: follow 1.14120190930: follow 1.19820191231: follow 1.05120200331: follow 1.26020200630: follow 1.33120200930: follow 2.09720201231: follow 2.26620210331: follow 2.41420210630: follow 2.67920210930: follow 2.33220211231: follow 2.05920220331: follow 2.21520220630: follow 1.96020220930: follow 2.07620221231: follow 2.07120230331: follow 2.10420230630: follow 2.00220230930: follow 1.94620231231: follow 2.29620240331: follow 2.31520240630: follow 2.49420240930: follow 2.54720241231: follow 2.43920250331: follow 2.47920250630: follow 2.42320250930: follow 2.71320251231: follow 2.840 0.84 1.95 3.07 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 662 · 2026 Q1

Ticker Value Weight QoQ
IVV $443M
14.1%
ADD
IEFA $156M
5.0%
TRIM
IJH $99M
3.1%
ADD
USIG $87M
2.8%
ADD
NVDA $84M
2.7%
TRIM
EMXC $83M
2.6%
ADD
SPYM $80M
2.5%
HOLD
MBB $76M
2.4%
ADD
NE $64M
2.0%
TRIM
SCHR $59M
1.9%
ADD
JQUA $58M
1.8%
ADD
JVAL $58M
1.8%
ADD
IWF $53M
1.7%
HOLD
AAPL $52M
1.7%
ADD
IUSB $51M
1.6%
ADD
XOM $40M
1.3%
ADD
SCMB $38M
1.2%
HOLD
JCPB $36M
1.1%
ADD
VEA $36M
1.1%
ADD
VTEB $35M
1.1%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.